Patents by Inventor Manuel Litchman

Manuel Litchman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer treatment with epothilones
    Patent number: 7875601
    Abstract: The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.
    Type: Grant
    Filed: April 19, 2006
    Date of Patent: January 25, 2011
    Assignee: Novartis AG
    Inventors: Terence O'Reilly, Markus Wartmann, Manuel Litchman, Pamela Cohen
  • Cancer treatment with epothilones
    Publication number: 20060223867
    Abstract: The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.
    Type: Application
    Filed: April 19, 2006
    Publication date: October 5, 2006
    Inventors: Terence O'Reilly, Markus Wartmann, Manuel Litchman, Pamela Cohen
  • Cancer treatment with epothilones
    Patent number: 7091226
    Abstract: The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.
    Type: Grant
    Filed: March 24, 2005
    Date of Patent: August 15, 2006
    Assignee: Novartis AG
    Inventors: Terence O'Reilly, Markus Wartmann, Manuel Litchman, Pamela Cohen
  • Cancer treatment with epothilones
    Publication number: 20050165071
    Abstract: The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.
    Type: Application
    Filed: March 24, 2005
    Publication date: July 28, 2005
    Inventors: Terence O'Reilly, Markus Wartmann, Manuel Litchman, Pamela Cohen
  • Cancer treatment with epothilones
    Publication number: 20040024033
    Abstract: The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.
    Type: Application
    Filed: August 1, 2003
    Publication date: February 5, 2004
    Inventors: Terence O'Reilly, Markus Wartmann, Manuel Litchman, Pamela Cohen
  • Cancer treatment with epothilones
    Patent number: 6635666
    Abstract: The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.
    Type: Grant
    Filed: August 9, 2001
    Date of Patent: October 21, 2003
    Assignee: Novartis AG
    Inventors: Terence O'Reilly, Markus Wartmann, Manuel Litchman, Pamela Cohen
  • Cancer treatment with epothilones
    Publication number: 20020028839
    Abstract: The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.
    Type: Application
    Filed: August 9, 2001
    Publication date: March 7, 2002
    Inventors: Terence O'Reilly, Markus Wartmann, Manuel Litchman, Pamela Cohen
  • Cancer treatment with epothilones
    Patent number: 6302838
    Abstract: The invention relates to the treatment of a proliferative disease, especially according to certain treatment regimens, with an epothilone, especially with epothilone A and more preferably epothilone B; as well as to the treatment of certain cancers with such an epothilone.
    Type: Grant
    Filed: January 19, 1999
    Date of Patent: October 16, 2001
    Assignee: Novartis AG
    Inventors: Terence O'Reilly, Markus Wartmann, Manuel Litchman, Pamela Cohen